Journal Article Summary
The article discusses a clinical trial called the ON-TIME 3 trial, which investigates the effects of fentanyl versus paracetamol on platelet inhibition in patients experiencing ST-elevation myocardial infarction (STEMI). This topic is significant because effective platelet inhibition is crucial for the treatment of STEMI, a serious heart condition that requires rapid intervention. Current guidelines recommend opioids like fentanyl for pain relief, but these drugs can delay the absorption of oral antiplatelet medications, potentially worsening patient outcomes. The trial aims to explore whether using paracetamol instead of fentanyl can enhance the effectiveness of platelet inhibition in these patients.
In this trial, 190 STEMI patients will be randomly assigned to receive either intravenous (IV) fentanyl or IV paracetamol, alongside crushed ticagrelor, a medication that inhibits platelet function. The primary goal is to measure the level of platelet reactivity units (PRU) immediately after a procedure called primary percutaneous coronary intervention (PCI). The researchers will collect data on pain levels and platelet inhibition at various points during and after treatment to assess the effectiveness of each analgesic approach.
While the study is well-designed, it has some limitations. For instance, there is no placebo group, which means the effects of paracetamol cannot be directly compared to a non-treatment scenario. Additionally, the trial's follow-up period is only one month, which may not be sufficient to draw conclusions about long-term outcomes. Patients should discuss the implications of this study with their healthcare providers, especially regarding pain management and the use of analgesics during STEMI treatment, to ensure they receive the most effective and safe care.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication. Always consult a licensed healthcare professional before using a medical device.
Article Cited
- Tavenier A. H., Hermanides R. S., Ottervanger J. P., Rasoul S., Slingerland R. J., Tolsma R., van Workum S., Kedhi E., et al.. A randomised, investigator-initiated, clinical trial of the effects of fentanyl on P2Y12-receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: rationale and design of the Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial. Netherlands Heart Journal 2019. DOI: 10.1007/s12471-019-1241-6. PMID: 30767166. PMCID: PMC6439041.
Featured Pill Pals Product
Pill Pals - Pill Cutter, Crusher, Splitter, and Holder (3 in 1) --- Three in One --- Dukal --- Over The Counter
Pill Pals – Pill Cutter, Crusher, Splitter, and Holder (3 in 1) — Three in One — Dukal — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
